Tandem Diabetes Care Inc (TNDM): R&D Expense
$193.11M
Year ended 2025-12-31
$187.75M
Trailing 12 months to 2026-06-30
+11.6%
3-year compound annual growth
+24.9%
5-year compound annual growth
+27.5%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $193.11M | -2.9% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $198.88M | +17.2% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $169.67M | +22.0% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $139.11M | +51.1% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $92.05M | +44.8% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $63.57M | +40.7% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $45.20M | +54.6% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $29.23M | +41.5% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $20.66M | +9.8% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $18.81M | +10.9% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $16.96M | +7.4% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $15.79M | +42.5% | 2017-03-08, From 2014-01-01 |
| 2013-12-31 | $11.08M | +23.0% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $9.01M | n/a | 2015-02-24, From 2012-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $193.11M | -2.9% |
| Embecta Corp. (EMBC) | 2025-09-30 | $37.30M | -52.7% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $65.85M | -10.6% |
| Haemonetics Corp (HAE) | 2026-03-28 | $59.77M | -4.7% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
| Penumbra Inc (PEN) | 2025-12-31 | $89.77M | -5.3% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $97.35M | +11.3% |
Compare TNDM, EMBC, INSP, OFIX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗